Correlation of deviation from intended cisplatin (CDDP) dose intensity with outcome in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) receiving concurrent chemoradiation (CRT)

被引：0
|
作者：
Liu, C. S.
Elser, C.
Huang, S.
Pond, G. R.
O'Sullivan, B.
Chen, E. X.
Waldron, J. N.
Goldstein, D.
Siu, L. L.
Kim, J.
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[2] Everest Clin Res Serv, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6052
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'
    Hanemaaijer, S. H.
    Kok, I. C.
    Fehrmann, R. S. N.
    van der Vegt, B.
    Gietema, J. A.
    Plaat, B. E. C.
    Vugt, M. A. T. M.
    Vergeer, M. R.
    Voortman, J.
    Leemans, C. R.
    Buter, J.
    Langendijk, J. A.
    Oosting, S. F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
    Powell, Steven Francis
    Gitau, Mark Mutuota
    Sumey, Christopher Joseph
    Reynolds, John T.
    Lohr, Michele
    McGraw, Steven
    Nowak, Ryan Kenneth
    Terrell, Andrew M.
    Jensen, Ashley Wayne
    Blanchard, Miran Joel
    Ellison, Christie
    Black, Lora Jane
    Thompson, Paul A.
    Gold, Kathryn A.
    Cohen, Ezra E. W.
    Lee, John H.
    Spanos, William Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
    Garcia, Enrique Sanz
    Zou, Jinfeng
    Avery, Lisa
    Spreafico, Anna
    Waldron, John
    Goldstein, David Paul
    Hansen, Aaron Richard
    Cho, John
    de Almeida, John R.
    Hope, Andrew
    Hosni, Ali
    Hahn, Ezra
    Perez-Ordonez, Bayardo
    Zhao, Zhen
    Smith, Christopher Gareth
    Zheng, Yangqiao
    Rosenfeld, Nitzan
    Singaravelan, Nittusha
    Bratman, Scott Victor
    Siu, Lillian L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] A Phase 1 Trial of Ketogenic Diet With Concurrent Chemoradiation (CRT) in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Anderson, C. M.
    Loth, E.
    Opat, E.
    Bodeker, K.
    Ahmann, L.
    Parkhurst, J.
    Sun, W.
    Furqan, M.
    Laux, D.
    Brown, H.
    Vollstedt, S.
    Follmer, K.
    Ma, D.
    Spitz, D.
    Fath, M.
    Buatti, J.
    Allen, B. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 898 - 898
  • [25] Docetaxel, ifosfamide and cisplatin (DIP) as induction chemotherapy (IC) followed by chemoradiation (CRT) in patients with locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)
    Specenier, Pol M.
    Rasschaert, Marika
    Van den Brande, Jan
    Huizing, Manon
    Dyck, Joke
    Altintas, Sevilay
    Van den Weyngaert, Danielle
    Van Laer, Carl
    Vermorken, Jan B.
    ANNALS OF ONCOLOGY, 2006, 17 : 181 - 181
  • [26] Gemcitabine (GEM), cisplatin (CDDP) and radiotherapy (RT) in the treatment of locally advanced head and neck squamous cell carcinoma (HNSCC): A feasibility study
    Merlano, M
    Marchetti, G
    Numico, G
    Di Costanzo, G
    Ricci, I
    Corvo, R
    Sanguineti, G
    Benasso, M
    ANNALS OF ONCOLOGY, 1998, 9 : 77 - 77
  • [27] Safety and efficacy of concurrent carboplatin or cetuximab chemoradiation in cisplatin ineligible locally advanced head and neck squamous cell carcinoma
    Marinho, Joana
    Laranja, Andre
    Leao, Ines
    Joaquim, Ana
    Vieira, Claudia
    Dinis, Jose
    Soares, Andre
    Moreira, Diana
    ORAL ONCOLOGY, 2021, 118
  • [28] Phase I study of concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with unresectable locally advanced squamous cell carcinoma of head and neck (SCCHN).
    Tahara, M
    Minami, H
    Mukai, H
    Kawada, K
    Kawashima, M
    Ogino, T
    Yamazaki, M
    Matsuura, K
    Hayashi, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 518S - 518S
  • [29] JADE: A phase (ph) III study to evaluate dostarlimab vs placebo (PBO) as sequential therapy after chemoradiation (CRT) in patients (pts) with locally advanced unresected head and neck squamous cell carcinoma (LA-HNSCC)
    Machiels, J-P.
    Burtness, B.
    Harrington, K. J.
    Saba, N. F.
    Tahara, M.
    Crossman, T.
    Hua, L.
    Perera, A. D.
    Theti, D. S.
    Zografos, E.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2024, 35 : S655 - S655
  • [30] Phase II trial of valproic acid combined with cisplatin-based chemoradiation in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) patients (pts).
    Mak, Milena Perez
    Pasini, Fatima Solange
    Diao, Lixia
    Garcia, Fabyane Oliveira Teixeira
    Takahashi, Tiago Kenji
    Amadio, Alex Vitorio
    Siqueira, Sheila Aparecida Coelho
    Sichero, Laura
    Snitcovsky, Igor M. L.
    Kulcsar, Marco Aurelio Vamondes
    Wang, Jing
    Castro, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345